Open an account

LENSAR

LNSR · NASDAQ

$5.81+$0.06 (+1.04%)TodayMarket closed ·
Prev close $5.75

About LNSR

LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. The company is headquartered in Orlando, Florida and currently employs 150 full-time employees. The company went IPO on 2020-09-21. The firm is focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. Its product portfolio includes the LENSAR Laser System (LLS), and the ALLY Robotic Cataract Laser Treatment System (ALLY). The firm has developed its ALLY Robotic Cataract Laser System as a compact, ergonomic system utilizing a fast dual-modality laser and integrating artificial intelligence (AI) into proprietary imaging and software. ALLY is designed to transform cataract surgery by utilizing the Company’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes its proprietary Streamline software technology, designed to guide surgeons to achieve better outcomes.

Employees
150
Headquarters
Orlando, Florida
Listed
Sep 21, 2020
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
lensar.com

LNSR key statistics

Market cap
71.38M
Price-earnings ratio
4.67
Dividend yield
—
Average volume
39.46K
Volume
51.95K
Open price
$5.75
High today
$5.90
Low today
$5.74
52 Week high
$12.94
52 Week low
$4.95

LENSAR (LNSR) at a glance

LENSAR (LNSR) last traded at $5.81, with a market cap of 71.38M and a price-to-earnings ratio of 4.67.

Today the stock has traded between $5.74 and $5.90. The current price is 1.2% above the day's low and 1.5% below its high.

Volume so far is 51.95K shares, above the average of 39.46K shares a day.

Over the past year LENSAR has ranged from $4.95 to $12.94, and now sits 11% of the way up that range.

LENSAR met or beat analyst EPS estimates in 2 of the last 8 quarters. In Q2 FY26 it reported $0.10 per share against an estimate of -$0.1683.

The average analyst price target is $11.22, 93.1% above the current price, from 2 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 2 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 4 analystsAvg $11.22
Low
$9.09
Now
$5.81
High
$13.65

LNSR earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 8 quarters, by 108.1% on average.

  1. Q3 FY24: reported -$0.13 per share against an estimate of -$0.3009
  2. Q4 FY24: reported -$1.61 per share against an estimate of -$0.1836
  3. Q1 FY25: reported -$2.32 per share against an estimate of -$0.1581
  4. Q2 FY25: reported -$0.15 per share against an estimate of -$0.0765
  5. Q3 FY25: reported -$0.31 per share against an estimate of -$0.051
  6. Q4 FY25: reported -$0.12 per share against an estimate of -$0.0714
  7. Q1 FY26: reported $0.00 per share against an estimate of $0.1887
  8. Q2 FY26: reported $0.10 per share against an estimate of -$0.1683

LNSR news

  • LENSAR Q2 2026 Earnings Call: Complete Transcript

  • 12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • Press releaseGlobe Newswire

    LENSAR® Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update

  • Avi Kapoor

    Crude Oil Gains Around 2%; Elbit Systems Shares Jump On Upbeat Earnings

  • Avi Kapoor

    Nasdaq Surges Over 100 Points; Academy Sports And Outdoors Posts Downbeat Earnings

  • 12 Health Care Stocks Moving In Monday's After-Market Session

  • Press releaseBusiness Wire

    Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

  • Press releasePRNewswire

    $TOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of SVT, SSBK, LNSR, iCAD to Protect Their Rights

Similar companies

Companies in the same industry as LENSAR

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.